Skip to main content
OpenTrials

Clinical trial condition

Bladder Cancer

Explore clinical trials studying Bladder Cancer. Study availability and eligibility vary by location and protocol.

771 public trials 174 recruiting studies
Refine in advanced search Browse all conditions

Bladder Cancer trial results

Completed

Tranexamic Acid During Cystectomy Trial (TACT)

NCT01869413

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Northern Alberta Urology Centre Edmonton, Alberta, Canada
  • St. Boniface General Hospital Winnipeg, Manitoba, Canada
  • Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada
  • St. Joseph's Healthcare Hamilton Hamilton, Ontario, Canada
View Trial Details
Completed

Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer

NCT02500121

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • University of Arizona at Dignity Health St. Joseph's Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
View all 28 locations
View Trial Details
Completed

A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer

NCT03558503

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
Locations
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • Loma Linda University Loma Linda, California, United States
  • Providence Medical Institute Santa Monica, California, United States
View all 19 locations
View Trial Details
Completed

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors

NCT03662204

Conditions
Adnexal Diseases, Bladder Cancer, Breast Cancer, +65 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Scottsdale Medical Imaging Research Scottsdale, Arizona, United States
  • Arizona Clinical Research Center, Inc. Tucson, Arizona, United States
  • Urological Associates of Southern Arizona, PC Tucson, Arizona, United States
View all 119 locations
View Trial Details
Completed

CARINAE for Stress Relief in Perioperative Care

NCT05184725

Conditions
Behavior, Behavioral Symptoms, Bladder Cancer, +33 more
Locations
  • Istituto di Ricovero e Cura per Anziani Ancona, Italy
  • Maastricht University Medical Center Maastricht, Netherlands
  • Hospital Reina Sofía Córdoba, Andalusia, Spain
  • Hospital San Joan de Deu Esplugues de Llobregat, Catalonia, Spain
View Trial Details
Completed

Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer

NCT01780545

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • University of Alabama Hematology Oncology Clinic at Medical West Birmingham, Alabama, United States
  • City of Hope: Duarte Duarte, California, United States
  • City of Hope: Antelope Valley Lancaster, California, United States
  • USC: Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 35 locations
View Trial Details
Completed

Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery

NCT00777491

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Georgia Cancer Center for Excellence at Grady Memorial Hospital Atlanta, Georgia, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center Boise, Idaho, United States
  • Cancer Institute at St. John's Hospital Springfield, Illinois, United States
View Trial Details

Related conditions